Skip to main content
Clinical Trials/NCT04384055
NCT04384055
Completed
Not Applicable

Predicting Outcomes for Covid-19 Using Sonography

Stanford University2 sites in 1 country165 target enrollmentMarch 21, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
COVID-19
Sponsor
Stanford University
Enrollment
165
Locations
2
Primary Endpoint
Number of Patients Experiencing Death, ICU Admission, Mechanical Ventilation, or Use of High-Flow Nasal Cannula
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

This study seeks to investigate the role of lung ultrasound in caring for Covid-19 positive patients and whether it can be used to predict patient deterioration. This information will be vital for healthcare workers who seek to identify Covid-19 pneumonia or patients at risk for deterioration early in the disease course.

Detailed Description

As Covid-19 continues to stress hospital-based resources (including personal protective equipment, ancillary staff availability, and imaging study utilization), it is important to assess whether alternative methods for evaluating patients can be utilized to appropriately triage and care for Covid-positive patients. Current limitations of caring for patients with Covid-19 include the exposure of ancillary healthcare workers (including radiological technicians) and the time/resources required to decontaminate traditional radiological equipment such as x-ray or computerized tomography (CT) machines. Point-of-care ultrasound (POCUS) has the potential to transform healthcare delivery due to its diagnostic and therapeutic expediency. It can be quickly performed at the bedside by experienced clinicians. It it has been shown to reliably and accurately diagnose patients with a variety of lung diseases, including pneumonia. This study seeks to investigate the role of lung ultrasound in caring for Covid-19 positive patients and whether it can be used to predict patient deterioration. This information will be vital for healthcare workers who seek to identify the virus or patients at risk for deterioration early in the disease course. Moreover, it has the potential to reduce the need for x-rays or CTs for Covid-19 patients, which has the potential to alleviate a significant burden currently being placed on the healthcare system.

Registry
clinicaltrials.gov
Start Date
March 21, 2020
End Date
November 15, 2021
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Any adult (18 or more years of age) presenting to the emergency department with symptoms suspicious for Covid-19
  • This individual underwent evaluation for Covid-19 via a nasopharyngeal RT-PCR
  • This individual received a lung ultrasound by the study authors within 28 days from initial evaluation

Exclusion Criteria

  • Any individual who did not receive a lung ultrasound within 28 days from initial evaluation for covid-19 related illness

Outcomes

Primary Outcomes

Number of Patients Experiencing Death, ICU Admission, Mechanical Ventilation, or Use of High-Flow Nasal Cannula

Time Frame: 28 days from initial evaluation

Composite primary outcome of death, ICU admission, mechanical ventilation, or use of high-flow nasal cannula (categorical)

Secondary Outcomes

  • Number of Patients Requiring Mechanical Ventilation(28 days from initial evaluation)
  • Length of Stay(28 days from initial evaluation)
  • Characterization of Ultrasound Findings(28 days from initial evaluation)
  • Number of Patients Requiring Supplemental Oxygen Usage(28 days from initial evaluation)
  • Duration of Supplemental Oxygen Usage(28 days from initial evaluation)

Study Sites (2)

Loading locations...

Similar Trials